Zobrazeno 1 - 10 of 25 pro vyhledávání: '"José Manuel Cifrián‐Martínez"'
1
Akademický článek
Simplified risk stratification based on cardiopulmonary exercise test: A Spanish two‐center experience
Autor: Amaya Martínez‐Meñaca, Alejandro Cruz‐Utrilla, Víctor Manuel Mora‐Cuesta, Raquel Luna‐López, Teresa Segura‐de la Cal, Ángela Flox‐Camacho, Pilar Alonso‐Lecue, Pilar Escribano‐Subias, José Manuel Cifrián‐Martínez
Publikováno v: Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract A simplified 4‐strata risk stratification approach based on three variables is widespread in pulmonary arterial hypertension (PAH) at follow‐up. This study aimed to assess the impact of replacing the 6‐min walk test (6MWT) with the pea
Externí odkaz: https://doaj.org/article/92750aa284ba48e5af5a195e918c904c
Zobrazit plný text záznamu
2
Akademický článek
Calcineurin inhibitors’ impact on cardiovascular and renal function, a descriptive study in lung transplant recipients from the North of Spain
Autor: Rita Nogueiras-Álvarez, Víctor Manuel Mora-Cuesta, José Manuel Cifrián-Martínez, María Ángeles de Cos-Cossío, María del Mar García-Sáiz
Publikováno v: Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Patients undergoing lung transplantation (LTx) need administration of immunosuppressive therapy following the procedure to prevent graft rejection. However, these drugs are not exempt from potential risks. The development of cardiovascular r
Externí odkaz: https://doaj.org/article/c81a713371a9405d99874615676f38a2
Zobrazit plný text záznamu
3
Akademický článek
A Retrospective Review of Calcineurin Inhibitors’ Impact on Cytomegalovirus Infections in Lung Transplant Recipients
Autor: Rita Nogueiras-Álvarez, Víctor Manuel Mora-Cuesta, José Manuel Cifrián Martínez, María Ángeles de Cos Cossío, María del Mar García Sáiz
Publikováno v: Transplantology, Vol 2, Iss 4, Pp 478-490 (2021)
Immunosuppressive therapy reduces the risk for allograft rejection but leaves recipients susceptible to infections. Cytomegalovirus (CMV) is one of the most frequent causes for infection after transplantation and increases the risk for allograft reje
Externí odkaz: https://doaj.org/article/e2fd046b11cd45e79550ec81cfff030e
Zobrazit plný text záznamu
7
A Retrospective Review of Calcineurin Inhibitors’ Impact on Cytomegalovirus Infections in Lung Transplant Recipients
Autor: José Manuel Cifrián Martínez, María del Mar García Sáiz, María Ángeles de Cos Cossío, Víctor Manuel Mora-Cuesta, Rita Nogueiras-Álvarez
Publikováno v: Transplantology, Vol 2, Iss 45, Pp 478-490 (2021)
Transplantology; Volume 2; Issue 4; Pages: 478-490
Immunosuppressive therapy reduces the risk for allograft rejection but leaves recipients susceptible to infections. Cytomegalovirus (CMV) is one of the most frequent causes for infection after transplantation and increases the risk for allograft reje
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20eea0acc0c64442bd47a949cbfadc01
https://www.mdpi.com/2673-3943/2/4/45
Zobrazit plný text záznamu
8
Lack of concordance between the different exercise test measures used in the risk stratification of patients with pulmonary arterial hypertension
Autor: Víctor M. Mora Cuesta, Amaya Martínez Meñaca, David Iturbe Fernández, Sandra Tello Mena, Pilar Alonso Lecue, Daniel Fernández Márquez, Begoña Sáinz‐Ezquerra Belmonte, María José Gallardo Ruiz, José Manuel Cifrián Martínez
Publikováno v: Pulmonary circulation. 2022;12:e12149
In pulmonary arterial hypertension (PAH) patients it is essential to perform a prognostic assessment to optimize the treatment. The aim of this study is to evaluate the risk stratification concordance assessed with different exercise test variables i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60ef698d938cbbd1fa1bad7b74714d22
https://hdl.handle.net/10902/27900
Zobrazit plný text záznamu
9
Early onset of azithromycin to prevent CLAD in lung transplantation: Promising results of a retrospective single centre experience
Autor: Marta Cristeto Porras, Víctor Manuel Mora Cuesta, David Iturbe Fernández, Sandra Tello Mena, Pilar Alonso Lecue, Laura Sánchez Moreno, Eduardo Miñambres García, Sara Naranjo Gozalo, Sheila Izquierdo Cuervo, José Manuel Cifrián Martínez
Publikováno v: Clinical transplantation 2022 Oct 11; e14832
Introduction: Azithromycin (AZI) may be an effective immune modulator in lung transplant (LT) recipients, and can decrease chronic lung allograft dysfunction (CLAD) rates, the leading cause of mortality after the first year post-LT. The aim of the st
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7635c266865bb02a82fa802649b3c4f2
https://pubmed.ncbi.nlm.nih.gov/36217992
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje